May 18, 2017 – At this week’s information-packed Coalition for Healthcare Communication’s Rising Leaders Conference, keynote speaker and former FDA Commissioner Robert Califf said that “healthcare marketers need to create a code of ethics to promote drugs for truthful and non-misleading uses outside their FDA-approved labels, commonly referred to as off-label promotion,” according to coverage of the meeting in MM&M.
“Given the deregulated state [of off-label promotion], you need to come up with a code of ethics,” Califf advised attendees at the Monday session, MM&M reported. “Your efforts should be truthful and non-misleading,” Califf added. “Truthful you get, non-misleading is really hard. It’s like a bad marriage; it’s not what you say. It’s what you didn’t say. The misleading part is where you need to focus.”
To view the full article, go to: http://www.mmm-online.com/legalregulatory/fda-off-label-promotion-califf-marketing-advertising-pharma/article/661852/?DCMP=EMC-MMM_Newsbrief_20170516&cpn=mmmcpn&spMailingID=17241742&spUserID=NzAzNDA1MTY4ODQS1&spJobID=1021335603&spReportId=MTAyMTMzNTYwMwS2
